Neurobiological outcomes of cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review
Open accessThe DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
Introduction: Obsessive-compulsive disorder (OCD) is characterized by recurrent distressing thoughts and repetitive behaviors, or mental rituals performed to reduce anxiety. Recent neurobiological techniques have been particularly convincing in suggesting that cortico-striatal-thalamic-cortico (CSTC) circuits, including orbitofrontal cortex (OFC) and striatum regions (caudate nucleus and putamen), are responsible for mediation of OCD symptoms. However, it is still unclear how these regions are affected by OCD treatments in adult patients. To address this yet open question, we conducted a systematic review of all studies examining neurobiological changes before and after first-line psychological OCD treatment, i.e., cognitive-behavioral therapy (CBT). Methods: Studies were included if they were conducted in adults with OCD and they assessed the neurobiological effects of CBT before and after treatment. Two databases were searched: PsycINFO and PubMed for the time frame up to May 2022. Results: We obtained 26 pre-post CBT treatment studies performed using different neurobiological techniques, namely functional magnetic resonance imaging (fMRI), Positron emission tomography (PET), regional cerebral blood flow (rCBF), 5-HT concentration, magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), Electroencephalography (EEG). Neurobiological data show the following after CBT intervention: (i) reduced activations in OFC across fMRI, EEG, and rCBF; (ii) decreased activity in striatum regions across fMRI, rCBF, PET, and MRI; (iii) increased activations in cerebellum (CER) across fMRI and MRI; (iv) enhanced neurochemical concentrations in MRS studies in OFC, anterior cingulate cortex (ACC) and striatum regions. Most of these neurobiological changes are also accompanied by an improvement in symptom severity as assessed by a reduction in the Y-BOCS scores. Conclusion: Cognitive-behavioral therapy seems to be able to restructure, modify, and transform the neurobiological component of OCD, in addition to the clinical symptoms. Nevertheless, further studies are necessary to frame the OCD spectrum in a dimensional way.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Extensive prior research has demonstrated that individuals with OCD show alterations in these components—most consistently in the No-Go P3—reflecting difficulties in suppressing prepotent responses and terminating action tendencies.”
From Neural correlates of response inhibition following cognitive behavioral therapy in obsessive–compulsive disorder: a randomized controlled EEG study (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, changes in No-Go–related ERP amplitudes have been shown to be sensitive to cognitive-behavioral interventions, making them suitable neural markers for treatment-related change.”
From Neural correlates of response inhibition following cognitive behavioral therapy in obsessive–compulsive disorder: a randomized controlled EEG study (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The OBQ was originally developed by the Obsessive Compulsive Cognitions Working Group [37] to assess dysfunctional belief domains implicated in cognitive models of OCD, including inflated responsibility and threat estimation, importance and control of thoughts, and perfectionism/need for certainty.”
From Neural correlates of response inhibition following cognitive behavioral therapy in obsessive–compulsive disorder: a randomized controlled EEG study (2026) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Interrater reliability: The kappa statistic
McHugh, M. L. (2012) · Biochemia Medica · doi:10.11613/bm.2012.031 · Cited by 19,877
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Baxter, L. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820090009002 · Cited by 1,293 · cited 2×
“(49) results, BT responders had significant bilateral decreases in caudate glucose metabolic rates that were greater than those seen in poor responders to treatment.”
BackgroundMethodMataix-Cols, D., Wooderson, S., Lawrence, N., Brammer, M. J., Speckens, A., & Phillips, M. L. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.6.564 · Cited by 929
Abramowitz, J. S., Deacon, B. J., Olatunji, B. O., Wheaton, M. G., Berman, N. C., Losardo, D., Timpano, K. R., McGrath, P. B., Riemann, B. C., Adams, T., et al. (2010) · Psychological Assessment · doi:10.1037/a0018260 · Cited by 848 · cited 2×
“Assessing potentially overlapping OC symptoms using dimensional measures, such as the Dimensional ObsessiveCompulsive Scale [DOCS; (31)], may therefore be a better approach to understand the relationship between specific OC dimensions and other variables, such as neurobiological correlates.”
BackgroundMethodObsessive-compulsive disorder: beyond segregated cortico-striatal pathways
Milad, M. R., & Rauch, S. L. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.11.003 · Cited by 847
Carpenter, J. K., Andrews, L. A., Witcraft, S. M., Powers, M. B., Smits, J. A. J., & Hofmann, S. G. (2018) · Depression and Anxiety · doi:10.1002/da.22728 · Cited by 846
Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder
Saxena, S., & Rauch, S. L. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70181-7 · Cited by 840 · cited 1×
“With respect to CSTC circuitry, functioning imaging studies have found orbitostriatal hyperconnectivity in OCD at baseline that normalizes after treatment (4).”
Background'Behavioral' Addictions: Do They Exist?
Holden, C. (2001) · Science · doi:10.1126/science.294.5544.980 · Cited by 746
Schwartz, J. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020023004 · Cited by 693 · cited 1×
“(50) studied glucose metabolic rates with PET before and after 10 weeks of structured exposure and response prevention (ERP) behavioral and cognitive treatment.”
BackgroundOlatunji, B. O., Davis, M. L., Powers, M. B., & Smits, J. A. J. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.020 · Cited by 659
Öst, L.-G., Havnen, A., Hansen, B., & Kvale, G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.06.003 · Cited by 655 · cited 1×
“, exposure and response prevention and/or cognitive therapy) already found to be effective for OCD in several meta-analyses (17, 25, 28).”
BackgroundRoles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction
Wise, R. A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.004 · Cited by 500
The Epidemiology and Differential Diagnosis of Obsessive-Compulsive Disorder
Rasmussen, S. A., & Eisen, J. L. (1992) · Zwangsstörungen / Obsessive-Compulsive Disorders · doi:10.1007/978-3-642-77608-3_1 · Cited by 493 · cited 1×
“OCD has been shown to be quite common with a 1% prevalence in the general population across many cultures (2).”
Backgroundvan den Heuvel, O. A., Remijnse, P. L., Mataix-Cols, D., Vrenken, H., Groenewegen, H. J., Uylings, H. B. M., van Balkom, A. J. L. M., & Veltman, D. J. (2008) · Brain · doi:10.1093/brain/awn267 · Cited by 454 · cited 1×
“These results suggest the existence of specific neurobiological underpinnings, potentially overlapping with the neurobiological correlates of other OCD dimensions, as previously reported (67, 68).”
ResultROSENBERG, D. R., MacMASTER, F. P., KESHAVAN, M. S., FITZGERALD, K. D., STEWART, C. M., & MOORE, G. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200009000-00008 · Cited by 377
Soomro, G. M., Altman, D. G., Rajagopal, S., & Oakley Browne, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001765.pub3 · Cited by 342
Maltby, N., Tolin, D. F., Worhunsky, P., O'Keefe, T. M., & Kiehl, K. A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2004.08.041 · Cited by 331
Nakao, T., Nakagawa, A., Yoshiura, T., Nakatani, E., Nabeyama, M., Yoshizato, C., Kudoh, A., Tada, K., Yoshioka, K., Kawamoto, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.039 · Cited by 307
Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder
McKay, D., Sookman, D., Neziroglu, F., Wilhelm, S., Stein, D. J., Kyrios, M., Matthews, K., & Veale, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.058 · Cited by 283
Simpson, H. B., Foa, E. B., Liebowitz, M. R., Huppert, J. D., Cahill, S., Maher, M. J., McLean, C. P., Bender, J., Marcus, S. M., Williams, M. T., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1932 · Cited by 248
Gürsel, D. A., Avram, M., Sorg, C., Brandl, F., & Koch, K. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.016 · Cited by 231
Clinical Predictors of Drug Response in Obsessive-Compulsive Disorder
Erzegovesi, S., Cavallini, M. C., Cavedini, P., Diaferia, G., Locatelli, M., & Bellodi, L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200110000-00006 · Cited by 224 · cited 1×
“, sexual contact with a relative) are ubiquitous and normal (18, 19), but the interpretation of the intrusion as overly significant, threatening or morally reprehensible differentiates OCD patients from healthy controls (HC) (20).”
BackgroundPerani, D., Garibotto, V., Gorini, A., Moresco, R. M., Henin, M., Panzacchi, A., Matarrese, M., Carpinelli, A., Bellodi, L., & Fazio, F. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.233 · Cited by 219
Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive–compulsive disorder
Kwon, J. S., Kim, J.-J., Lee, D. W., Lee, J. S., Lee, D. S., Kim, M.-S., Lyoo, I. K., Cho, M. J., & Lee, M. C. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00104-x · Cited by 205 · cited 1×
“Previous studies found that OCD patients have shown above-normal pre-treatment glucose metabolism in caudate nucleus, thalamus, OFC and ACC, which are brain structures that form functional neural circuits thought to be hyperactive in OCD (53, 60).”
ResultObsessive–compulsive symptoms induced by atypical antipsychotics. A review of the reported cases
Lykouras, L., Alevizos, B., Michalopoulou, P., & Rabavilas, A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00039-3 · Cited by 190
Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder
Denys, D., de Vries, F., Cath, D., Figee, M., Vulink, N., Veltman, D. J., van der Doef, T. F., Boellaard, R., Westenberg, H., van Balkom, A., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.012 · Cited by 170
Saxena, S., Gorbis, E., O'Neill, J., Baker, S. K., Mandelkern, M. A., Maidment, K. M., Chang, S., Salamon, N., Brody, A. L., Schwartz, J. M., et al. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002134 · Cited by 159 · cited 2×
“Previous studies found that OCD patients have shown above-normal pre-treatment glucose metabolism in caudate nucleus, thalamus, OFC and ACC, which are brain structures that form functional neural circuits thought to be hyperactive in OCD (53, 60).”
MethodResultCognitive-behavioral group therapy in obsessive–compulsive disorder: a randomized clinical trial
Volpato Cordioli, A., Heldt, E., Braga Bochi, D., Margis, R., Basso de Sousa, M., Fonseca Tonello, J., Gus Manfro, G., & Kapczinski, F. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000070785 · Cited by 158
Ebert, D., Speck, O., König, A., Berger, T., Hennig, J., & Hohagen, F. (1997) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00016-4 · Cited by 154
Reggente, N., Moody, T. D., Morfini, F., Sheen, C., Rissman, J., O’Neill, J., & Feusner, J. D. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716686115 · Cited by 154 · cited 1×
“A recent report (37) highlights that pre-treatment connectivity may reflect an individual’s capacity to recover after intensive CBT, independent of the baseline symptom severity.”
BackgroundQuality of life in obsessive-compulsive disorder before and after treatment
Moritz, S., Rufer, M., Fricke, S., Karow, A., Morfeld, M., Jelinek, L., & Jacobsen, D. (2005) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2005.04.002 · Cited by 150
Effects of behavior therapy on regional cerebral blood flow in obsessive–compulsive disorder
Nakatani, E., Nakgawa, A., Ohara, Y., Goto, S., Uozumi, N., Iwakiri, M., Yamamoto, Y., Motomura, K., Iikura, Y., & Yamagami, T. (2003) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(03)00069-6 · Cited by 150 · cited 1×
“(55) investigated rCBF, using the Xenon inhalation method, of the basal ganglia in 53 OCD patients treated with BT compared to 31 HC.”
MethodNeurobiology of Obsessive-Compulsive Disorder:Serotonin and Beyond
Westenberg, H. G. M., Fineberg, N. A., & Denys, D. (2007) · CNS Spectrums · doi:10.1017/s1092852900002479 · Cited by 148
Adams, K. H., Hansen, E. S., Pinborg, L. H., Hasselbalch, S. G., Svarer, C., Holm, S., Bolwig, T. G., & Knudsen, G. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005055 · Cited by 147
Ting, J. T., & Feng, G. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.04.010 · Cited by 143
Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.132 · Cited by 138
Nabeyama, M., Nakagawa, A., Yoshiura, T., Nakao, T., Nakatani, E., Togao, O., Yoshizato, C., Yoshioka, K., Tomita, M., & Kanba, S. (2008) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2007.11.001 · Cited by 137 · cited 1×
“(41) investigated the alterations of brain function in OCD patients and changes after clinical improvement due solely to 12 weeks-BT.”
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder
Ting, J. T., & Feng, G. (2008) · Current Chemical Genomics · doi:10.2174/1875397300802010062 · Cited by 125
Naaijen, J., Lythgoe, D. J., Amiri, H., Buitelaar, J. K., & Glennon, J. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.009 · Cited by 117
Role of serotonin in obsessive-compulsive disorder
Baumgarten, H. G., & Grozdanovic, Z. (1998) · British Journal of Psychiatry · doi:10.1192/s0007125000297857 · Cited by 114 · cited 1×
“, sexual contact with a relative) are ubiquitous and normal (18, 19), but the interpretation of the intrusion as overly significant, threatening or morally reprehensible differentiates OCD patients from healthy controls (HC) (20).”
BackgroundSerotoninergic mechanisms in the treatment of obsessive–compulsive disorder
Goddard, A. W., Shekhar, A., Whiteman, A. F., & McDougle, C. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.12.009 · Cited by 112
Freyer, T., Klöppel, S., Tüscher, O., Kordon, A., Zurowski, B., Kuelz, A.-K., Speck, O., Glauche, V., & Voderholzer, U. (2011) · Psychological Medicine · doi:10.1017/s0033291710000309 · Cited by 105 · cited 1×
“(42) used event-related fMRI, to examine 10 OCD patients before and after CBT, in addition to 10 HC, during a probabilistic reversal learning task.”
MethodEvidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder
Richter, M. A., de Jesus, D. R., Hoppenbrouwers, S., Daigle, M., Deluce, J., Ravindran, L. N., Fitzgerald, P. B., & Daskalakis, Z. J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.300 · Cited by 100
Starck, G., Ljungberg, M., Nilsson, M. K. L., Jönsson, L., Lundberg, S., Ivarsson, T., Ribbelin, S., EKHOLM, S. E., Carlsson, A., Forssell-Aronsson, E. B., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0045-4 · Cited by 100
Bystritsky, A., Saxena, S., Maidment, K., Vapnik, T., Tarlow, G., & Rosen, R. (1999) · Psychiatric Services · doi:10.1176/ps.50.3.412 · Cited by 93
Cervin, M., Miguel, E. C., Güler, A. S., Ferrão, Y. A., Erdoğdu, A. B., Lazaro, L., Gökçe, S., Geller, D. A., Yulaf, Y., Başgül, Ş. S., et al. (2022) · Psychological Medicine · doi:10.1017/s0033291720005437 · Cited by 93 · cited 1×
“Current OCD conceptualizations (64); deems that this disorder can be better understood as a spectrum of multiple, potentially overlapping, symptom dimensions (namely, contamination, responsibility for harm and mistakes, unacceptable thoughts,”
BackgroundMoody, T. D., Morfini, F., Cheng, G., Sheen, C., Tadayonnejad, R., Reggente, N., O'Neill, J., & Feusner, J. D. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.192 · Cited by 86 · cited 1×
“(36) investigated changes in brain connectivity of 43 OCD patients after 4-weeks intensive CBT treatment.”
BackgroundO'Neill, J., Gorbis, E., Feusner, J. D., Yip, J. C., Chang, S., Maidment, K. M., Levitt, J. G., Salamon, N., Ringman, J. M., & Saxena, S. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.11.010 · Cited by 84 · cited 1×
“(59) investigated neurochemical alterations, induced by a short intensive 4-week CBT treatment, in the cingulate cortex.”
BackgroundObsessive compulsive disorder and the glutamatergic system
Kariuki-Nyuthe, C., Gomez-Mancilla, B., & Stein, D. J. (2014) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000017 · Cited by 81
Learning From Animal Models of Obsessive-Compulsive Disorder
Monteiro, P., & Feng, G. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.020 · Cited by 78
Morgiève, M., N'Diaye, K., Haynes, W. I. A., Granger, B., Clair, A.-H., Pelissolo, A., & Mallet, L. (2014) · Psychological Medicine · doi:10.1017/s0033291713002237 · Cited by 74
The tic-related obsessive-compulsive disorder phenotype and treatment implications.
Miguel, E. C., do Rosário-Campos, M. C., Shavitt, R. G., Hounie, A. G., & Mercadante, M. T. (2001) · PubMed · Cited by 71
Fluvoxamine Treatment and D2 Receptors: a Pet Study on OCD Drug-Naïve Patients
Moresco, R. M., Pietra, L., Henin, M., Panzacchi, A., Locatelli, M., Bonaldi, L., Carpinelli, A., Gobbo, C., Bellodi, L., Perani, D., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301199 · Cited by 70
Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder
Naaijen, J., Zwiers, M. P., Amiri, H., Williams, S., Durston, S., Oranje, B., Brandeis, D., Boecker-Schlier, R., Ruf, M., Wolf, I., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.260 · Cited by 70
Yang, X., Sun, J., Luo, J., Zhong, Z., Li, P., Yao, S., Xiong, H., Huang, F.-F., & Li, Z. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.07.048 · Cited by 67 · cited 1×
“Resting-state functional magnetic resonance imaging studies A recent work (35) investigated the coordination of pre- and post-CBT SBA using regional-homogeneity (Re-Ho), a voxelbased measure of brain activity which evaluates the similarity, or synchronization, between the time series of a given voxel and its nearest n…”
MethodYamanishi, T., Nakaaki, S., Omori, I. M., Hashimoto, N., Shinagawa, Y., Hongo, J., Horikoshi, M., Tohyama, J., Akechi, T., Soma, T., et al. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.07.004 · Cited by 64 · cited 1×
“(56) employed single photon emission computed tomography (SPECT) to investigate the effects of a 12-week CBT in OCD patients resistant to SSRI treatment compared to non-treatment resistant patients.”
MethodSchiepek, G., Tominschek, I., Heinzel, S., Aigner, M., Dold, M., Unger, A., Lenz, G., Windischberger, C., Moser, E., Plöderl, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071863 · Cited by 63 · cited 1×
“(44) studied activation patterns related to the psychotherapeutic process, in order to identify critical instabilities and discontinuous transitions of the change dynamics.”
BackgroundLissemore, J. I., Sookman, D., Gravel, P., Berney, A., Barsoum, A., Diksic, M., Nordahl, T. E., Pinard, G., Sibon, I., Cottraux, J., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0128-4 · Cited by 60 · cited 2×
“(52) used PET combined with the α[11C] methyl-L-tryptophan tracer to examine changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment.”
BackgroundMethodRodriguez, C. I., Kegeles, L. S., Levinson, A., Ogden, R. T., Mao, X., Milak, M. S., Vermes, D., Xie, S., Hunter, L., Flood, P., et al. (2015) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2015.06.001 · Cited by 59
Pozza, A., & Dèttore, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.056 · Cited by 58
Self-citationThorsen, A. L., Kvale, G., Hansen, B. K. A., & van den Heuvel, O. A. (2018) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0142-4 · Cited by 57 · cited 1×
“These results suggest the existence of specific neurobiological underpinnings, potentially overlapping with the neurobiological correlates of other OCD dimensions, as previously reported (67, 68).”
ResultNeuroendocrine and behavioral responses to mCPP in Obsessive–Compulsive Disorder
Khanna, S. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00048-2 · Cited by 56
Li, P., Yang, X., Greenshaw, A. J., Li, S., Luo, J., Han, H., Liu, J., Zhong, Z., Guo, Z., Xiong, H., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.963 · Cited by 52
Zai, G., Brandl, E. J., Müller, D. J., Richter, M. A., & Kennedy, J. L. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.83 · Cited by 49
Sesia, T., Bizup, B., & Grace, A. A. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200154x · Cited by 49
Glutamate Genetics in Obsessive-Compulsive Disorder: A Review.
Rajendram, R., Kronenberg, S., Burton, C. L., & Arnold, P. D. (2017) · Europe PMC (PubMed Central) · Cited by 48
Apostolova, I. I., Block, S., Buchert, R., Osen, B., Conradi, M., Tabrizian, S., Gensichen, S., Schroeder-Hartwig, K., Fricke, S., Rufer, M., et al. (2010) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2010.08.012 · Cited by 47 · cited 1×
“(51), using dynamic PET, showed an increase in glucose metabolism of the right caudate nucleus in 16 patients who responded to both pharmacological treatment and CBT, compared to non-responders.”
MethodSimpson, H. B., Slifstein, M., Bender, J., Xu, X., Hackett, E., Maher, M. J., & Abi-Dargham, A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.023 · Cited by 47
Li, Y., Zhang, C., Weidacker, K., Zhang, Y., He, N., Jin, H., Chen, W., Voon, V., Edden, R. A. E., & Yan, F. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2160-1 · Cited by 44
Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors
Bellini, S., Fleming, K. E., De, M., McCauley, J. P., Petroccione, M. A., D'Brant, L. Y., Tkachenko, A., Kwon, S., Jones, L. A., & Scimemi, A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1906-17.2017 · Cited by 43
Rangaprakash, D., Tadayonnejad, R., Deshpande, G., O’Neill, J., & Feusner, J. D. (2021) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00358-8 · Cited by 43
Barahona-Corrêa, B., Camacho, M., Castro-Rodrigues, P., Costa, R. M., & Oliveira-Maia, A. J. (2015) · Frontiers in Psychology · doi:10.3389/fpsyg.2015.01798 · Cited by 41
Zhong, Z., Yang, X., Cao, R., Li, P., Li, Z., Lv, L., & Zhang, D. (2019) · Brain and Behavior · doi:10.1002/brb3.1201 · Cited by 39
Hennig‐Fast, K., Michl, P., Müller, J., Niedermeier, N., Coates, U., Müller, N., Engel, R. R., Möller, H., Reiser, M. F., & Meindl, T. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.001 · Cited by 38 · cited 1×
“(65) reported that 20 OCD patients, scanned with fMRI while imagining guilt-inducing scenarios, showed increased responsiveness of the superior frontal, bilateral ACC and superior temporal gyrus.”
BackgroundAdvances in the Cognitive Behavioural Treatment of Obsessive Compulsive Disorder
Shafran, R., Radomsky, A. S., Coughtrey, A. E., & Rachman, S. (2013) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2013.773061 · Cited by 32
Low versus Standard Dose mCPP Challenge in Obsessive-Compulsive Patients
Erzegovesi, S. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00178-0 · Cited by 32 · cited 1×
“, sexual contact with a relative) are ubiquitous and normal (18, 19), but the interpretation of the intrusion as overly significant, threatening or morally reprehensible differentiates OCD patients from healthy controls (HC) (20).”
BackgroundWhiteside, S. P. H., Abramowitz, J. S., & Port, J. D. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.04.004 · Cited by 31 · cited 1×
“(58) used Proton Magnetic Resonance Spectroscopic Imaging (1H MRS) to investigate differences in absolute concentrations of neurochemicals (i.”
MethodP300 in obsessive–compulsive disorder: Source localization and the effects of treatment
Andreou, C., Leicht, G., Popescu, V., Pogarell, O., Mavrogiorgou, P., Rujescu, D., Giegling, I., Zaudig, M., Juckel, G., Hegerl, U., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.003 · Cited by 29
International prescribing practices in obsessive-compulsive disorder (OCD)
Brakoulias, V., Starčević, V., Belloch, A., Dell’Osso, L., Ferrão, Y. A., Fontenelle, L. F., Löchner, C., Marazziti, D., Martin, A. J., Matsunaga, H., et al. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2541 · Cited by 28 · cited 1×
“Concurrent psychiatric medication was not considered as an exclusion criterion since, in routine clinical practice, the majority of patients with OCD receive psychiatric medication (29).”
BackgroundPozza, A., Coradeschi, D., & Dèttore, D. (2013) · Florence Research (University of Florence) · Cited by 27
Self-citationCao, R., Yang, X., Luo, J., Wang, P., Meng, F., Xia, M., He, Y., Zhao, T., & Li, Z. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110037 · Cited by 27 · cited 1×
“(48) collected diffusion MRI (dMRI) data from 34 unmedicated OCD patients before and after 12 weeks of CBT.”
BackgroundMa, N., Tan, L., Wang, Q., Li, Z.-X., & Li, L. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2005.10.005 · Cited by 26
Baioui, A., Pilgramm, J., Kagerer, S., Walter, B., Vaitl, D., & Stark, R. M. (2013) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2013.04.006 · Cited by 22 · cited 1×
“(43) studied 12 OCD patients with washing compulsions in a symptom-provocation fMRI experiment.”
BackgroundThe Role of Cingulate Cortex Dysfunction in Obsessive– Compulsive Disorder
Saxena, S., O’Neill, J., & Rauch, S. L. (2009) · Oxford University Press eBooks · doi:10.1093/oso/9780198566960.003.0027 · Cited by 17
Atmaca, M., Yıldırım, H., Yilmaz, S., Caglar, N., Mermi, O., Gürok, M. G., Kekilli, Y., & Türkçapar, M. H. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1072220 · Cited by 15 · cited 1×
“(61) investigated neurochemical changes in the brain of OCD patients undergoing CBT therapy, by means of magnetic resonance spectroscopy (MRS).”
MethodNeurotransmitter Dysregulation in OCD
Graat, I., Figee, M., & Denys, D. A. J. P. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190228163.003.0025 · Cited by 12
(2007) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890423349.15861 · Cited by 11
Atmaca, M., Yıldırım, H., Yilmaz, S., Caglar, N., Baykara, S., Kekilli, Y., Köseoğlu, F., & Türkçapar, M. H. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-2449 · Cited by 9 · cited 1×
“(46), compared 12 OCD patients with12 HC using MRI, and found reduced pre-treatment pituitary gland volumes in the OCD group.”
ResultWhat is the impact of pharmacotherapy on psychotherapy for obsessive-compulsive disorder?
Marazziti, D., Pozza, A., Avella, M. T., & Mucci, F. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1775814 · Cited by 9 · cited 1×
“Despite these benefits, harmful residual symptoms, and treatment nonresponse (nearly one-third of patients with OCD fail to respond to CBT) (21, 23, 24) are common among patients who have undergone CBT, and more research, including psychobiological research, is needed to identify processes that may predict more favora…”
BackgroundSelf-citationThe Pharmacological Treatment of Refractory OCD
Pittenger, C. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190228163.003.0041 · Cited by 6
Sampaio, T. P. D. A., Lima, C., Corregiari, F., & Bernik, M. (2016) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2015-1721 · Cited by 5 · cited 1×
“(57) investigated whether pre-treatment platelet rich plasma (PRP) 5-HT concentration was associated with latency of treatment response and final response to an ERP protocol for OCD.”
Background
Research works printed but not linked: 5
- 2013, Diagnostic and Statistical Manual of Mental Disorders: DSM-5.
- Abramowitz, 2017, The Wiley Handbook of Obsessive Compulsive Disorders., 10.1002/97811188902332017 · doi:10.1002/97811188902332017
- 2022, Covidence Systematic Review Software.
- 2014, Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies.
- Morgiéve, 2014, Dynamics of psychotherapy-related cerebral haemodynamic changes in obsessive compulsive disorder using a personalized exposure task in functional magnetic resonance imaging, Psychol Med., 44, 1461, 10.1017/S0033291713002237 · DOI · Paper page
Cited by
Yu, J., Xu, Q., Ma, L., Huang, Y., Zhu, W., Liang, Y., Wang, Y., Tang, W., Zhu, C., & Jiang, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1401623 · Cited by 22
Ding, Z., Shang, T., Ding, Z., Yang, X., Qi, J., Qin, X., Chen, Y., Lv, D., Li, T., Ma, J., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.011 · Cited by 9
Neurobiological correlates of CBT response in OCD through the analysis of resting state networks
Sousa, M. M., Bertolín, S., Picó‐Pérez, M., Costa, A. D., Vieira, R., Alonso, P., Menchón, J. M., Morgado, P. F., & Soriano‐Mas, C. (2025) · International Journal of Clinical and Health Psychology · doi:10.1016/j.ijchp.2025.100585 · Cited by 5
“Increased activity after treatment has also been reported in the parietal cortex and cerebellum (Poli et al., 2022). rsFC studies further reveal changes in the brain connectivity of patients with OCD following CBT treatments.”
Miccoli, M., & Poli, A. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1369216 · Cited by 7
Self-citationPoli, A., Zifaro, M., & Miccoli, M. (2025) · Psychiatry Research Communications · doi:10.1016/j.psycom.2025.100209 · Cited by 7
Self-citation
Metadata
- Authors
- Poli, A., Pozza, A., Orrù, G., Conversano, C., Ciacchini, R., Pugi, D., Angelo, N. L., Angeletti, L. L., Miccoli, M., & Gemignani, A.
- Affiliations
- University of Pisa (IT)
- University of Siena (IT)
- University of Florence (IT)
- Corresponding author
- Pozza, Andrea
- ORCID
- Venue
- Frontiers in Psychiatry
- Publisher
- Frontiers Media SA
- Published
- 2022-12-09
- Volume
- 13
- Pages
- 1063116-1063116
- ISSN
- 1664-0640 (ISSN-L)
- PMC
- PMC9780289
- OpenAlex
- W4311947638
- Cited by
- 25
- References
- 95
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 7 · 2023: 1
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- obsessive-compulsive disorder, cognitive behavioral therapy, neurobiological changes, orbitofrontal cortex, striatum, caudate nucleus, putamen, cerebellum, anterior cingulate cortex, serotonin, regional cerebral blood flow, neurochemical changes, treatment response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
